Physician profile
Aron Rubin
NPI 1396788956
$16,931.05
in general payments reported to CMS, 2019-2025
32 companies · $3,323 in 2025
The $3,323 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,971 · 2020: $1,758 · 2021: $2,321 · 2022: $2,246 · 2023: $2,251 · 2024: $3,061 · 2025: $3,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,255 · Education: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,255.04 |
| Education | $380.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,169.28 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $2,734.30 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,921.24 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Genzyme Corporation | $1,877.93 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,459.17 | 2020-2025 | Dupixent |
| Mylan Specialty L.P. | $1,196.40 | 2019-2024 | Yupelri |
| Viatris Specialty LLC | $607.31 | 2025 | Yupelri |
| Philips North America LLC | $555.40 | 2020-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Insmed, INC. | $411.69 | 2020-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $400.37 | 2019-2022 | |
| Verona Pharma, INC. | $388.46 | 2025 | Ohtuvayre |
| Regeneron Pharmaceuticals, INC. | $377.84 | 2020-2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $328.58 | 2019-2024 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $238.69 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.94 | 2021-2023 | Xifaxan, Trulance |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $179.53 | 2021-2025 | Smartvest |
| Amgen INC. | $142.61 | 2022-2024 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $106.50 | 2022 | |
| Inogen, INC. | $99.59 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Optinose US, INC. | $92.85 | 2019-2020 | |
| Amarin Pharma, INC. | $75.47 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $52.08 | 2019 | |
| Horizon Therapeutics Plc | $36.62 | 2022 | |
| Sunovion Pharmaceuticals INC. | $34.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.04 | 2019 | |
| Mallinckrodt Hospital Products INC. | $28.00 | 2021 | |
| Paratek Pharmaceuticals, INC. | $23.72 | 2023 | Nuzyra |
| Pfizer INC. | $22.00 | 2019 | |
| United Therapeutics Corporation | $18.08 | 2021 | |
| Arbor Pharmaceuticals, INC. | $16.66 | 2019 | |
| Circassia INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aron Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.